Fundraising Fox

Bluewhale

Philadelphia, US · Founded 2022 · Delaware corporation · 1 known investors

bluewhale.bio ↗

Synecta develops cell-derived nanoparticles that activate immune cells for cell therapy manufacturing, improving potency and reducing costs. The product accelerates the delivery of CAR-engineered cell therapies with a simplified workflow.

BiotechDeep TechMedical Devicesin /bluewhale-bio

Founders & leadership

PK
Peter KellerExecutive Officer, Director
PM
Paul MeisterDirector
EH
Elaine HeronDirector
PC
Paula CannonDirector
BM
Beate Mueller-TiemannDirector

Investors · 1

Novalis LifeSciencesPortsmouth

Reported raises · per SEC filings

Form D private placements
▶$5MraisedOct 2025 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Elaine HeronDirector
  • Peter KellerExecutive Officer, Director
  • Paul MeisterDirector
  • Paula CannonDirector
  • Beate Mueller-TiemannDirector
Offering amount
$15M
Amount sold
$5M
First sale
Oct 2025
Incorporated
Corporation, Delaware, 2022
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.